China Meheco Group CoSHSE:600056 -0.80%65 FCF Yield % is 8.85 as of Jun. 30, 2026, which is 191% above its 10-year median of 3.04. GuruFocus rates SHSE:600056 with a GF Score™ of 65/100 and a GF Value™ of ¥10.49 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 117 Medical Distribution companies, China Meheco Group Co ranks better than 71.79% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for China Meheco Group Co's FCF Yield % or its related term are showing as below:
SHSE:600056'
s FCF Yield % Range Over the Past 10 Years
Min: -7.05 Med: 3.04 Max: 17.49
Current: 8.85
During the past 13 years, the highest FCF Yield % of China Meheco Group Co was 17.49%. The lowest was -7.05%. And the median was 3.04%.
SHSE:600056's FCF Yield % is ranked better than 71.79% of 117
companies
in the Medical Distribution industry
Industry Median: 2.61
vs SHSE:600056: 8.85
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
China Meheco Group Co FCF Yield % Related Terms
China Meheco Group Co FCF Yield % Historical Data
* Premium members only.
The historical data trend for China Meheco Group Co's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600056 vs MCK, CAH, COR: FCF Yield % Comparison
For the Medical Distribution subindustry, China Meheco Group Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Meheco Group Co FCF Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China Meheco Group Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where China Meheco Group Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Meheco Group Co (SHSE:600056) has a FCF Yield % of 8.85 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on China Meheco Group Co and its competitors. This is 191% above median its historical median of 3.04. According to the industry distribution chart, China Meheco Group Co ranks #33 out of 117 companies in the Medical Distribution industry, placing it in the top 28.2%.
Is China Meheco Group Co's FCF Yield % too high?
China Meheco Group Co's current FCF Yield % of 8.85 is 191% above median its 10-year median of 3.04. The Medical Distribution industry median FCF Yield % is 2.61. China Meheco Group Co's value of 8.85 is 239.1% above this industry median. Based on the distribution chart, China Meheco Group Co ranks #33 out of 117 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, China Meheco Group Co has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China Meheco Group Co's FCF Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, China Meheco Group Co ranks #33 out of 117 companies for FCF Yield %. This puts China Meheco Group Co in the upper half of its industry. The industry median FCF Yield % is 2.61. China Meheco Group Co's value of 8.85 is 239.1% above this benchmark. While the company's 10-year median is 3.04 vs. the industry median of 2.61, China Meheco Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Distribution company?
The median FCF Yield % among Medical Distribution companies is 2.61, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Meheco Group Co's current FCF Yield % of 8.85 is 239.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on China Meheco Group Co and its competitors. For the Medical Distribution industry, the median FCF Yield % is 2.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Meheco Group Co's current FCF Yield % is 8.85, which is 191% above median its own 10-year median of 3.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Meheco Group Co stock overvalued right now?
Based on GuruFocus' analysis, China Meheco Group Co (SHSE:600056) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥10.49, compared to a current price of ¥8.68 — trading 17.3% below its estimated fair value. The current FCF Yield % is 8.85, which is 191% above median its 10-year median of 3.04 and 239.1% above the Medical Distribution industry median of 2.61. China Meheco Group Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For China Meheco Group Co (SHSE:600056), the current FCF Yield % is 8.85 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Meheco Group Co (SHSE:600056) Overvalued in 2026?
Based on GuruFocus' analysis, China Meheco Group Co stock appears to be undervalued.
The current stock price of ¥8.68 is trading 17.3% below its estimated GF Value™ of ¥10.49.
GuruFocus considers China Meheco Group Co to be Modestly Undervalued.
Key valuation signals for SHSE:600056:
FCF Yield %: 8.85 (191% above median its 10-year median of 3.04)
GF Value™: ¥10.49 vs. price of ¥8.68 (17.3% below fair value)
Industry Position: 239.1% above the Medical Distribution median (#33 of 117)
No single metric tells the full story. See the SHSE:600056 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Meheco Group Co Ltd is engaged in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. It offers botanic medicines and herbal products, as well as exports of natural medicines, including herbs, spices, plant extracts, bee products, and Chinese traditional medicines. The company's business scope covers the whole industry chain, from research and development, cultivation and processing, manufacturing, distribution, and logistics to international trading, academic promotion, and technical service. The corporation provides trading services for customers in the pharmaceutical and chemical field, covering APIs, preparations, biologicals, blood products, and others.
65GF Score
Get the complete analysis for SHSE:600056
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600056 has been successfully added to your 
